Gabriela Ecco – Startup Investor Profile

Gabriela Ecco is a Senior Associate at ND Capital, a venture capital firm investing across disruptive technologies in life, physical, and data sciences. ND Capital’s investment thesis revolves around the convergence of scientific disciplines leading to breakthroughs. They focus on nurturing their portfolio companies by fostering creativity, intellect, and passion while aiming to build long-lasting impactful businesses. With a third fund of $335 million fully invested and a fourth fund in progress, ND Capital invests across sectors and technologies at various stages. They operate in the United States and Europe, with teams strategically placed in Silicon Valley, Switzerland, and the Cayman Islands. Gabriela Ecco’s track record includes serving as a board observer for companies like EVIR Therapeutics, Vandria, and Osasuna Therapeutics. While specific information on investment check size and partnership styles is limited, her involvement with ND Capital signifies an active role in fostering growth and innovation within the venture capital space.

Location:

Country: Switzerland

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website: https://www.nd.capital/

AI Reasoning: Searches found ND Capital’s team page confirming Gabriela Ecco as a board observer and multiple press releases showing ND Capital led Vandria’s Series A on December 14, 2023. Additional funding activity from Vandria had a second closing in August 2024 (Aug 21-22, 2024) where ND Capital remained an investor. The most recent publicly dated investment linked to ND Capital and Gabriela Ecco’s portfolio is the Vandria second closing on Aug 21, 2024. Calculating from the provided reference date, that investment occurred 14 months ago. However, Gabriela is also a board observer of EVIR Therapeutics and Osasuna Therapeutics; EVIR had a Series A announced Jul 2024? – no dated ND Capital-led deal after Aug 21, 2024 was found in searches. Given the latest verifiable investment activity tied to her portfolio is Aug 21, 2024 (approximately 14 months prior), this falls into the window between 12 and 6 months? Wait: Aug 21, 2024 to Nov 1, 2025 is 14 months – which is more than 12 months, corresponding to not-active. However earlier Vandria first close was Dec 14, 2023 (22 months prior). The August 2024 second close is the latest, at 14 months ago. Therefore tag should be not-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.